Product Name | MF | CAS | Details |
---|
(1S,2R)-2-(2-Benzylamino-1-hydroxyethyl)-6-fluorochromane | C18H20FNO2 | 129050-27-7 | Details |
6,7-Dihydro-4H-[1,2,3]oxadiazolo[4,3-c][1,4]oxazin-8-ium-3-olate | C5H6N2O3 | 623565-56-0 | Details |
Deschloro clomiphene | C26H29NO | 19957-52-9 | Details |
2-Methyl-6-(propan-2-yl)aniline hydrochloride | C10H16ClN | 2309465-45-8 | Details |
Limaprost | C22H36O5 | 74397-12-9 | Details |
Piperacillin oxalylamide | C23H29N5O8S | 64844-70-8 | Details |
CAPN12 antibody | Details |
3-Amino-N-(3,4-dihydro-2H-pyrrol-5-yl)benzenesulfonamide | C10H13N3O2S | 379255-71-7 | Details |
mGluR5 Ligand, CDPPB | C23H16N4O | 781652-57-1 | Details |
Methyl 2-amino-5-(propan-2-yl)benzoate hydrochloride | C11H15NO2·HCl | 1221726-14-2 | Details |
3’-deoxy-3’-fluorosangivamycin | C12H14FN5O4 | 146897-64-5 | Details |
B-[(1E)-3-Chloro-1-propen-1-yl]boronic acid | C3H6BClO2 | 491879-29-9 | Details |
3-(4-Nitro-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanoic acid | C11H8N2O6 | 15728-05-9 | Details |
1-(2'C-Methyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one | C11H14N2O7 | 2072145-17-4 | Details |
(2-Butoxypyridin-3-yl)methanamine | C10H16N2O | 851773-51-8 | Details |
DPH1 antibody | Details |
N-(2,4-Difluoro-6-nitrophenyl)acetamide | C8H6F2N2O3 | 441-30-5 | Details |
Fmoc-Tyr(SO3H)-OH barium salt | C24H23BaNO8S | 78553-20-5 | Details |
Affinity Purified anti-Cat IgG Fc Antibody | Details |
11-Methyl-5-(morpholin-4-ylmethyl)-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one | C16H21N3O2S | 737814-05-0 | Details |
2,6-Dichlorobenzaldehyde oxime | C7H5Cl2NO | 25185-95-9 | Details |
[3-Fluoro-4-(piperidin-1-yl)phenyl]methanol | C12H16FNO | 677312-75-3 | Details |
L-threo-hex-?2-?enaric acid 1,?4-lactone | C6H6O7 | 66757-69-5 | Details |
2,2-Dimethylheptan-1-amine | C9H21N | 143689-06-9 | Details |
rac-(3R,6S)-6-Methylpiperidine-3-carboxamide hydrochloride | C7H14N2O.ClH | 2241141-04-6 | Details |
Rheumatoid Factor IgG ELISA Kit | Details |
Human IgA ELISA kit | Details |
2-Chloro-1-N-(1-phenylethyl)benzene-1,4-diamine | C14H15ClN2 | 1040084-84-1 | Details |
2,6-Dichlorobenzohydrazide | C7H6Cl2N2O | 867151-44-8 | Details |
tert-Butyl 3-(4-hydroxyphenyl)propanoate | C13H18O3 | 51458-31-2 | Details |
Ethyl 5-(3,4-dimethoxyphenyl)-5-oxopentanoate | C15H20O5 | 101499-71-2 | Details |
1-(Azidomethyl)naphthalene | C11H9N3 | 55210-79-2 | Details |
trans-1-Benzyl-4-methylpyrrolidine-3-carboxylic acid ethyl ester | C14H19NO2 | 473914-76-0 | Details |
2-(4-Chloro-2-methyl-3-oxobutan-2-yl)-2,3-dihydro-1H-isoindole-1,3-dione | C13H12ClNO3 | 1803604-32-1 | Details |
2-Hydrazino-5-(trifluoromethyl)-1,3,4-thiadiazole | C3H3F3N4S | 299440-05-4 | Details |
Dhrs3 Blocking Peptide | Details |
Des(isopropoxyethyl) bisoprolol | C13H21NO3 | 62572-93-4 | Details |
(4-Nitrophenyl)methyl (γR,2R,3S)-α-diazo-3-[(1R)-1-hydroxyethyl]-γ-methyl-β,4-dioxo-2-azetidinebutanoate | C17H18N4O7 | 90822-24-5 | Details |
N-(2-(3,4-dimethoxyphenyl)ethyl)(4-(tert-butyl)phenyl)formamide | C21H27NO3 | 352218-35-0 | Details |
5-[(3-Methoxyphenyl)methyl]-1,3,4-oxadiazol-2-amine | C10 H11 N3 O2 | 1016691-89-6 | Details |
4-Methyl-2-methylaminopyrimidine | C6H9N3 | 15231-63-7 | Details |
N5-Phenylpyridine-2,5-diamine hydrochloride | C11H12ClN3 | 1955524-40-9 | Details |
1-[4-Fluoro-3-(trifluoromethyl)phenyl]ethan-1-amine | C9H9F4N | 1098068-92-8 | Details |
(2-Cyclohexylethyl)hydrazine dihydrochloride | C8H20Cl2N2 | 1355355-60-0 | Details |
2-Amino-1-(2-methylphenyl)ethan-1-one hydrochloride | C9H12ClNO | 7148-94-9 | Details |
3-(N-Methylamino)-L-alanine | C4H10N2O2 | 15920-93-1 | Details |
H-KRRWKKNFIAVSAANRFKKISSSGAL-OH | Details |
N-(Phenylsulfonyl)stearamide | C24H41NO3S | 197080-84-5 | Details |
2-[3-(Ethanesulfonyl)phenyl]acetic acid | C10H12O4S | 1363179-55-8 | Details |
tert-Butyl (3S)-3-azidopyrrolidine-1-carboxylate | C9H16N4O2 | 125552-56-9 | Details |
3-[[[4-[(4-Fluorophenyl)methoxy]-3-methylphenyl]methyl]amino]-benzoic acid | C22H20FNO3 | 2376590-40-6 | Details |
Methyl 4-(Bromomethyl)-2-methylbenzoate | C10H11BrO2 | 74733-28-1 | Details |
H-LVEAFGGATK-OH | Details |
4-Chloro-2-(3-methoxyphenyl)quinazoline | C15H11ClN2O | 1019449-61-6 | Details |
CD8b antibody (PE) | Details |
PHA 665752 | C32H34Cl2N4O4S | 477575-56-7 | Details |
PLANH1 antibody (FITC) | Details |
N-(Benzo[D]thiazol-2-ylmethyl)benzamide | C15H12N2OS | 117998-90-0 | Details |
3-(1-Methyl-1H-pyrazol-4-yl)furan-2-carboxylic acid | C9H8N2O3 | 1934391-99-7 | Details |
2, 3:5,6-Bis-O-(1-ethylpropylidene)-D-glycero-L-talo-heptonic acid gamma-lactone | Details |
4-[2-(Methylsulfanyl)ethyl]aniline | C9H13NS | 233772-17-3 | Details |
H-VLSNDVCAQV-OH | Details |
TNFSF4 Blocking Peptide | Details |
4-(4-Chlorophenyl)-2-oxobutanoic acid | C10H9ClO3 | 76400-21-0 | Details |
HIV2 ROD rev antibody (biotin) | Details |
1,1,4-Trioxo-2H,3H-benzo[E]thiin-6-carboxylic acid | C10H8O5S | 1391272-62-0 | Details |
2-(5-Chloropyridin-2-yl)-2-oxoethyl acetate | C9H8ClNO3 | 1797380-84-7 | Details |
Methyl 2-acetamido-3-O-benzyl-4,6-O-benzylidene-b-D-glucopyranoside | C23H27NO7 | Details |
4-Methyl-1,3-thiazole-5-carbonitrile | C5H4N2S | 408526-37-4 | Details |
1-Methyl-2-(prop-2-yn-1-yloxy)benzene | C10H10O | 5652-20-0 | Details |
(t-Bu)PhCPhos Pd G4 | Details |
[6-(Cyclohexyloxy)pyridin-3-yl]methylamine | C12H18N2O | 928648-57-1 | Details |
4-(2-Hydroxypropyl)-3-methyl-4,5-dihydro-1H-pyrazol-5-one | C7H12N2O2 | 10244-76-5 | Details |
2-[3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]acetic acid | C18H16N2O3 | 70598-13-9 | Details |
L-Glycero-L-galacto-heptose | C7H14O7 | 20585-65-3 | Details |
5-Amino-2-methoxy-N-methylbenzene-1-sulfonamide | C8H12N2O3S | 88508-45-6 | Details |
3-[(Pyridin-3-ylmethyl)sulfamoyl]benzoic acid | C13H12N2O4S | 733031-16-8 | Details |
4-(2-propynyloxy)benzenecarboxaldehyde | C10H8O2 | 5651-86-5 | Details |
Human IL3 ELISA Kit | Details |
1-[(4-Chloro-3-nitrophenyl)methyl]-1,2-dihydropyridin-2-one | C12H9ClN2O3 | 1097788-36-7 | Details |
3-Bromo-5H,6H,7H,8H-imidazo[1,2-a]pyridin-6-amine | C7H10BrN3 | 1536180-99-0 | Details |
GATA3 antibody | Details |
Human HGF ELISA kit | Details |
FBXL5 antibody | Details |
2-Amino-2-(oxolan-2-yl)acetic acid | C6H11NO3 | 61886-75-7 | Details |
H-VFIGVNDLER^-OH | Details |
HECA Blocking Peptide | Details |
TMEM35 antibody | Details |
PFKFB2 antibody (Ser483) | Details |
DDX52 Blocking Peptide | Details |
(2S,3S)-2-Azido-3-methylpentanoic acid cyclohexanamine salt | C12H24N4O2 | 1487380-39-1 | Details |
tert-Butyl 5-(methylamino)pentanoate hydrochloride | 1379371-52-4 | Details |
tert-Butyl N-[2-(prop-2-yn-1-ylsulfanyl)ethyl]carbamate | C10H17NO2S | 1058159-06-0 | Details |
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate hydrochloride | C20H24Cl2N2O5 | 2414962-06-2 | Details |
5-Bromo-2-cyclopropylpyridine hydrochloride | 2138357-62-5 | Details |
[5-(Trifluoromethyl)-1,3,4-thiadiazol-2-yl]methanol | C4H3F3N2OS | 1823329-50-5 | Details |
(3-Bromo-2,5-dimethylphenyl)methanol | C9H11BrO | 247575-34-4 | Details |
NFkB p65 antibody (Thr505) | Details |
6-(Hydroxymethyl)-2-oxa-5,8-diazaspiro[3.5]nonan-7-one | C7H12N2O3 | 2089255-11-6 | Details |
3-(1,3-Thiazol-4-yl)benzoic acid | C10H7NO2S | 1083368-99-3 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |